WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Keli Walbert will join the Apellis Board of Directors, effective immediately. Ms.
The MIAA Board of Directors spent nearly two hours on a frigid Wednesday morning sifting through 26 potential rule change proposals. When the smoke cleared, the board agreed on 13 of the proposals.